by Elena Iemma | Jul 27, 2023
Immunogenicity risk assessment of synthetic peptide drugs and their impurities – ScienceDirect
by Elena Iemma | Sep 22, 2022
Innovative Preclinical Assessment Tools for Safety and Efficacy of Protein and Peptide Therapeutics… of Peptides and P-ANDAS
by Annie De Groot | Sep 23, 2020
Addressing Immunogenicity of Observed and Theoretical Impurities for Peptide Abbreviated New Drug Applications